Vaxcyte, Inc. Profile Avatar - Palmy Investing

Vaxcyte, Inc.

Vaxcyte, Inc., a clinical-stage biotechnology vaccine company, develops novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent investigational pneumococcal conjugate vaccine that is in …

Biotechnology
US, San Carlos [HQ]
Value per Employee (VpE) · Surveys · Talents

Employees Analysis

Value per Employee (VpE)

No VpE graphs at the moment.

Employee Surveys

Employees Asked: -

No survey available at the moment.

Talent Acquisition

Permanent Employees

Last 12 Months:
Wage Range
Employees: -
Min.:$n/A
Avg.:$n/A
Max.:$n/A
Highest Demand Within Q3:

Vaxcyte, Inc. can't present the data

Top Demand Within Q3:

Not available for Vaxcyte, Inc.

Temporary Employees H1Bs

Last 12 Months:
Wage Range
Employees: -
Min.:$n/A
Avg.:$n/A
Max.:$n/A
Highest Demand Within Q3:

Vaxcyte, Inc. can't present the data

Top Demand Within Q3:

    Not available for Vaxcyte, Inc.

geographical
binding & acquisition

U.S. · Company Locations
Worldwide · Talent Acquisition
End of PCVX's Analysis
CIK: 1649094 CUSIP: 92243G108 ISIN: US92243G1085 LEI: - UEI: -
Secondary Listings
PCVX has no secondary listings inside our databases.